KR20210048729A - Compositions containing roasted chestnut inner skin extract - Google Patents
Compositions containing roasted chestnut inner skin extract Download PDFInfo
- Publication number
- KR20210048729A KR20210048729A KR1020190132751A KR20190132751A KR20210048729A KR 20210048729 A KR20210048729 A KR 20210048729A KR 1020190132751 A KR1020190132751 A KR 1020190132751A KR 20190132751 A KR20190132751 A KR 20190132751A KR 20210048729 A KR20210048729 A KR 20210048729A
- Authority
- KR
- South Korea
- Prior art keywords
- yulpi
- roasted
- extract
- cosmetic composition
- roasting
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 235000014036 Castanea Nutrition 0.000 title abstract description 15
- 241001070941 Castanea Species 0.000 title abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 31
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- 230000002087 whitening effect Effects 0.000 claims abstract description 9
- 230000036560 skin regeneration Effects 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 230000000694 effects Effects 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 16
- 235000013376 functional food Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 11
- 235000013824 polyphenols Nutrition 0.000 description 20
- 150000008442 polyphenolic compounds Chemical class 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 18
- 102000029816 Collagenase Human genes 0.000 description 16
- 108060005980 Collagenase Proteins 0.000 description 16
- 229960002424 collagenase Drugs 0.000 description 16
- 238000000605 extraction Methods 0.000 description 16
- 230000002401 inhibitory effect Effects 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 15
- 102000003425 Tyrosinase Human genes 0.000 description 14
- 108060008724 Tyrosinase Proteins 0.000 description 14
- 239000003963 antioxidant agent Substances 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229930003935 flavonoid Natural products 0.000 description 11
- 235000017173 flavonoids Nutrition 0.000 description 11
- 150000002215 flavonoids Chemical class 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- -1 restrictors Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940079894 benzophenone-9 Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Abstract
Description
본 발명은 로스팅 율피 추출물을 유효성분으로 포함하는 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and a health functional food comprising a roasted Yulpi extract as an active ingredient.
피부는 신체 중 가장 큰 기관으로 항상 외부환경과 직접 접하고 있으면서 여러 가지 자극이나 건조한 환경으로부터 생체를 보호하는 보호막의 역할을 하고 있으며, 다른 기관에 비하여 새로운 세포의 생성과 소멸이 활발히 일어난다.The skin is the largest organ in the body, always in direct contact with the external environment, and acts as a protective film to protect the living body from various stimuli or dry environments, and the generation and destruction of new cells occurs more actively than other organs.
또한, 물리적인 찰과상으로부터 신체를 보호하고, 신체 내부의 수분 손실을 막아주며 태양에서 발생되는 자외선으로부터 보호해줄 뿐만 아니라, 몸의 체온을 조절해주는 매우 중요한 역할을 담당하고 있다.In addition, it protects the body from physical abrasions, prevents moisture loss inside the body, protects against ultraviolet rays generated from the sun, and plays a very important role in regulating body temperature.
이러한 피부는 여러 가지 물리적 요인, 외부환경적 요인, 감염 등으로 인해 피부의 오염과 건조, 트러블, 피부 면역체계 이상 등의 문제가 발생한다.Such skin has problems such as contamination, dryness, troubles, and abnormal skin immune system due to various physical factors, external environmental factors, and infections.
특히, 현대의 급격한 산업발전에 따라, 대기공해, 수질공해 등의 공해문제가 심각해지고, 주거환경의 개선에 따른 거주공간의 강한 냉난방에 의해 피부의 거칠어짐, 건조, 노화 등과 같이 피부가 외부환경으로부터 큰 영향을 받고 있다.In particular, with the rapid industrial development of the modern era, pollution problems such as air pollution and water pollution become serious, and the skin is exposed to external environments such as roughening, drying, aging, etc. due to the strong cooling and heating of the living space due to the improvement of the residential environment. Has been greatly influenced by
인간의 피부는 내인성 노화(intrinsic aging)와 광노화에 의해 점차 피부가 얇아지고 주름이 증가하며, 탄력이 감소될 뿐만 아니라 자외선 노출에 의해 기미와 주근깨가 증가하게 된다. 특히, 내인성 노화는 호르몬 분비가 감소하거나 면역세포의 기능과 활성이 저하됨에 따라 생체 구성 단백질들의 생합성이 줄어들면서 발생하는데 이는 활성산소 증가에 따라 급속히 진행된다. Human skin gradually becomes thinner due to intrinsic aging and photoaging, wrinkles increase, elasticity decreases, and spots and freckles increase due to UV exposure. In particular, endogenous aging occurs when the secretion of hormones decreases or the function and activity of immune cells decreases, resulting in decreased biosynthesis of bio-constituent proteins, which rapidly progresses as free radicals increase.
상기 활성산소에 의해 생성되는 과산화지질은 조직 손상을 유발하고 세포의 쇠퇴를 촉진시키며 각종 염증반응과 질병들을 초래하므로 이러한 현상을 방지하기 위해 국내외 화장품에는 다양한 항산화제가 함유되어 있다. 상기 항산화제는 활성산소에 전자를 전달하여 자유라디칼을 소거하고 세포의 손상을 방지하는 역할을 하는데 합성 항산화제로는 butylated hydroxyanisole(BHA), butylated hydroxytoluene(BHT) 및 tertiary butylhydroquinone(TBHQ) 등이 주로 사용되고 있다. Lipid peroxidation produced by the active oxygen causes tissue damage, promotes cell degeneration, and causes various inflammatory reactions and diseases. To prevent this phenomenon, various antioxidants are contained in domestic and foreign cosmetics. The antioxidants transfer electrons to free radicals to remove free radicals and prevent damage to cells.As synthetic antioxidants, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), and tertiary butylhydroquinone (TBHQ) are mainly used. have.
이러한 합성 항산화제는 효과와 경제성 때문에 많이 사용되어 왔지만 다량 섭취 또는 흡수하면 체내 에너지 생산과 세포대사 및 호흡작용을 방해하며 간, 신장, 순환계 등에 독성 작용을 일으키는 문제점이 있다. 이러한 합성 항산화제의 단점을 극복하고자 보리, 블루베리, 밤, 콩 등으로부터 추출된 천연 항산화제가 활용되고 있다.These synthetic antioxidants have been widely used because of their effectiveness and economy, but when ingested or absorbed in large amounts, they interfere with the body's energy production, cell metabolism, and respiration, and cause toxic effects in the liver, kidneys, and circulatory systems. To overcome the shortcomings of these synthetic antioxidants, natural antioxidants extracted from barley, blueberries, chestnuts, beans, etc. are being used.
상기 식물계에 널리 분포되어 있는 2차 대사산물의 하나인 페놀성 화합물은 항산화 활성을 가진다고 알려져 있는데, 이러한 페놀성 화합물은 항산화, 해독, 항암, 면역기능 증강 등 다양한 생리활성기능을 나타내며 천연물 유래로서 인체에 안전성이 높아 신규 천연물질로부터 항산화 물질을 분리하여 기존 합성 항산화제를 대체하려는 연구가 활발히 진행 중이다.Phenolic compounds, which are one of the secondary metabolites widely distributed in the plant system, are known to have antioxidant activity.These phenolic compounds exhibit various physiological activities such as antioxidant, detoxification, anticancer, and immune function enhancement, and are derived from natural products. Due to its high safety, research is actively underway to replace existing synthetic antioxidants by separating antioxidants from new natural substances.
한편, 우리나라는 전 세계 밤(chestnut) 생산량의 약 22%를 생산하는 최대 생산국이지만, 산림청(Korea forest service, 2014) 조사에 따르면 국내 밤 생산은 농촌 인구감소와 인건비 상승으로 인해 2013년 64,184톤으로 최대 생산을 보인 이후, 2017년 53,042 톤으로 감소하고 있는 추세이다. 충남의 밤 생산비율은 전국의 40.9%이며 전년 대비 16.6%가 증가하여 전국의 밤 생산 감소에도 충남의 밤 생산은 꾸준히 유지되고 있다.Meanwhile, Korea is the largest producer of about 22% of the world chestnut production, but according to the Korea Forest Service (2014) survey, domestic chestnut production reached 64,184 tons in 2013 due to a decrease in rural population and an increase in labor costs. After the peak production, it has been decreasing to 53,042 tons in 2017. The production rate of chestnuts in Chungnam is 40.9% of the country, an increase of 16.6% compared to the previous year. Despite the decrease in chestnut production in the country, chestnut production in Chungnam is steadily maintained.
상기 밤은 조단백질 6.6%, 조섬유 2.3%, 조회분 1.7%, 조지방 0.9% 및 여러 가지 무기질 등으로 구성되어 있으며, 밤의 부산물인 율피는 버려지지 않고 현재 차, 화장품, 사료 등으로 많이 활용되고 있다. 그뿐만 아니라, 율피는 중금속 흡착률이 높아 생물흡착제로 사용할 수 있으며, 천연염료, 반추가축용 사료 등 율피의 기능성 연구도 활발히 진행 중이다.The chestnut is composed of 6.6% crude protein, 2.3% crude fiber, 1.7% crude ash, 0.9% crude fat, and various minerals.Yulpi, a by-product of chestnuts, is not discarded and is currently widely used as tea, cosmetics, feed, etc. . In addition, Yulpi can be used as a bio-adsorbent due to its high rate of adsorption of heavy metals, and functional studies of Yulpi such as natural dyes and feed for ruminants are actively underway.
본 발명은 천연물인 율피를 이용하여 우수한 기능성 및 항산화능을 가지면서 인체에 무해한 화장품 소재 및 건강기능식품을 제공하고자 한다. The present invention is to provide a cosmetic material and health functional food harmless to the human body while having excellent functionality and antioxidant activity by using a natural product, Yulpi.
본 발명의 목적은 로스팅 율피 추출물을 유효성분으로 포함하는 화장료 조성물을 제공하는데 있다.It is an object of the present invention to provide a cosmetic composition comprising a roasted Yulpi extract as an active ingredient.
또한, 본 발명의 다른 목적은 상기 로스팅 율피 추출물을 유효성분으로 포함하는 건강기능식품을 제공하는데 있다. In addition, another object of the present invention is to provide a health functional food comprising the roasting yulpi extract as an active ingredient.
상기한 목적을 달성하기 위한 본 발명의 화장료 조성물은 로스팅된 율피를 이용한 로스팅 율피 추출물을 유효성분으로 포함할 수 있다.The cosmetic composition of the present invention for achieving the above object may include a roasted Yulpi extract using roasted Yulpi as an active ingredient.
상기 로스팅 율피 추출물은 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매로 추출된 것일 수 있다.The roasted Yulpi extract may be extracted with water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof.
상기 혼합용매는 20 내지 99 부피%의 메탄올, 에탄올, 부탄올 또는 프로판올 수용액일 수 있다.The mixed solvent may be an aqueous solution of 20 to 99% by volume of methanol, ethanol, butanol or propanol.
상기 로스팅된 율피는 율피를 160 내지 280 ℃, 바람직하게는 190 내지 250 ℃의 온도로 로스팅한 것일 수 있다.The roasted Yulpi may be roasted at a temperature of 160 to 280 °C, preferably 190 to 250 °C.
상기 로스팅 율피 추출물은 20 내지 50 kHz의 진동수 및 50 내지 700 W의 파워의 초음파기로 20 내지 80분 동안 처리된 것일 수 있다.The roasting Yulpi extract may be processed for 20 to 80 minutes with an ultrasonicator having a frequency of 20 to 50 kHz and a power of 50 to 700 W.
상기 초음파 처리 시 추출온도는 50 내지 90 ℃일 수 있다.During the ultrasonic treatment, the extraction temperature may be 50 to 90°C.
상기 화장료 조성물은 피부 미백 및 피부 재생 효과를 갖는 것일 수 있다.The cosmetic composition may have skin whitening and skin regeneration effects.
또한, 상기한 다른 목적을 달성하기 위한 본 발명의 건강기능식품은 로스팅된 율피를 이용한 로스팅 율피 추출물을 유효성분으로 포함할 수 있다.In addition, the health functional food of the present invention for achieving the other object described above may include a roasted yulpi extract using roasted yulpi as an active ingredient.
본 발명의 로스팅 율피 추출물을 포함하는 조성물은 독성이 없으며, 티로시나제 저해능 및 콜라게나제 저해능이 우수할 뿐만 아니라 총 폴리페놀의 함량, 총 플라보노이드의 함량 및 DPPH 라디칼 소거능이 높다. The composition comprising the roasted Yulpi extract of the present invention is not toxic, has excellent tyrosinase inhibitory ability and collagenase inhibitory ability, as well as high content of total polyphenols, content of total flavonoids, and high DPPH radical scavenging ability.
본 발명은 로스팅 율피 추출물을 유효성분으로 포함하는 화장료 조성물 및 건강기능식품에 관한 것이다.
The present invention relates to a cosmetic composition and a health functional food comprising a roasted Yulpi extract as an active ingredient.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 화장료 조성물은 로스팅 율피 추출물을 유효성분으로 포함한다.The cosmetic composition of the present invention comprises a roasting yulpi extract as an active ingredient.
상기 율피는 밤의 과육으로부터 외피를 제거하여 과육의 표면에 보존된 것으로서 밤의 속껍질을 의미한다. 이러한 율피는 다수의 페놀성 수산기를 지닌 축합형 탄닌이 25%의 함유량으로 함유되어 있어 다양한 곳에 사용되고 있다.The yulpi is preserved on the surface of the flesh by removing the outer skin from the flesh of the chestnut, and means the inner shell of the chestnut. This Yulpi contains 25% of condensed tannins with many phenolic hydroxyl groups, so it is used in various places.
본 발명의 로스팅은 율피의 풋내를 제거하고, 율피의 품질을 결정하는 기능성 성분의 향상, 색과 향을 향상시키는 과정을 의미하는 것으로서, 로스팅은 160 내지 280 ℃, 바람직하게는 190 내지 250 ℃에서 3 내지 8분, 바람직하게는 4 내지 5분 동안 수행해야 기능성 성분이 향상된다. The roasting of the present invention refers to the process of removing the green inside of Yulpi, improving the functional ingredients that determine the quality of Yulpi, and improving color and scent. Roasting is performed at 160 to 280 °C, preferably at 190 to 250 °C. Functional ingredients are improved only when performed for 3 to 8 minutes, preferably 4 to 5 minutes.
상기 로스팅 율피 추출물은 추출용매 하에서 초음파처리를 통해 추출되는 것으로서, 구체적으로 로스팅된 율피와 추출용매가 1 : 10 내지 30의 중량비, 바람직하게는 1 : 15 내지 25의 중량비로 혼합되어 20 내지 50 kHz, 바람직하게는 30 내지 40 kHz의 진동수 및 50 내지 700 W, 바람직하게는 150 내지 400 W 파워의 초음파기로 50 내지 90 ℃, 바람직하게는 60 내지 80 ℃하에서 20 내지 80분, 바람직하게는 40 내지 60분 동안 처리된다. The roasted Yulpi extract is extracted through ultrasonic treatment under an extraction solvent, and specifically, the roasted Yulpi and the extraction solvent are mixed in a weight ratio of 1: 10 to 30, preferably 1: 15 to 25, and 20 to 50 kHz , Preferably, a frequency of 30 to 40 kHz and an ultrasonic wave of 50 to 700 W, preferably 150 to 400 W power at 50 to 90°C, preferably at 60 to 80°C for 20 to 80 minutes, preferably 40 to Treated for 60 minutes.
로스팅된 율피를 추출 시 초음파 추출이 아니라 열수 추출 또는 마이크로파 추출인 경우에는 긴 추출시간으로 인하여 폴리페놀이 파괴되어 항산화, 피부미백 및 피부재생 효과가 낮을 수 있다.In the case of extraction of roasted Yulpi, not ultrasonic extraction, but hot water extraction or microwave extraction, polyphenols are destroyed due to a long extraction time, so that antioxidant, skin whitening, and skin regeneration effects may be low.
상기 로스팅된 율피와 추출용매의 중량비가 상기 범위를 벗어나는 경우에는 추출물에 로스팅된 율피의 유효성분이 적은 양으로 추출될 수 있다. When the weight ratio of the roasted Yulpi and the extraction solvent is out of the above range, the active ingredient of the roasted Yulpi may be extracted in a small amount.
또한, 초음파기의 진동수 및 파워가 상기 하한치 미만인 경우에는 로스팅된 율피의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 유효성분의 추출이 평형을 이루어 생산량의 증가가 없는 반면 목적물질 이외의 다른 물질이 다량으로 추출되어 추출효과가 저하될 수 있다. In addition, when the frequency and power of the ultrasonicator are less than the lower limit, the active ingredient of the roasted Yulpi can be extracted in a small amount, and when the frequency and power of the ultrasonicator are higher than the upper limit, the extraction of the active ingredient is balanced and there is no increase in the production amount. A large amount of other substances may be extracted and the extraction effect may be lowered.
또한, 추출온도 및 추출시간이 상기 하한치 미만인 경우에는 로스팅된 율피의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 독성물질이 발생할 수 있다.In addition, when the extraction temperature and extraction time are less than the lower limit, the active ingredient of the roasted Yulpi may be extracted in a small amount, and when the extraction temperature and the extraction time are greater than the upper limit, toxic substances may be generated.
상기 추출물을 추출하는 추출용매는 물, 탄소수 1 내지 4의 저급알코올, 에틸렌글리콜, 에틸에테르 또는 이들의 혼합용매이다. 상기 저급알코올로는 20 내지 99 부피%의 메탄올, 에탄올, 부탄올 또는 프로판올 수용액을 들 수 있으며, 바람직하게는 우수한 항산화, 피부미백 및 피부재생 효과를 위하여 30 내지 60 부피%의 에탄올 수용액을 들 수 있다.The extraction solvent for extracting the extract is water, a lower alcohol having 1 to 4 carbon atoms, ethylene glycol, ethyl ether, or a mixed solvent thereof. The lower alcohol may include 20 to 99 vol% of methanol, ethanol, butanol or propanol aqueous solution, preferably 30 to 60 vol% of ethanol aqueous solution for excellent antioxidant, skin whitening and skin regeneration effects. .
본 발명의 로스팅된 율피 추출물은 화장료 조성물 외에 건강기능식품에도 사용될 수 있다.
The roasted Yulpi extract of the present invention can be used in health functional foods in addition to cosmetic compositions.
본 명세서에서 로스팅된 율피을 언급하면서 사용되는 용어 '추출물'은 추출용매를 처리하여 얻은 조추출물뿐만 아니라 로스팅 율피 추출물의 가공물도 포함한다. 예를 들어, 로스팅 율피 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The term'extract' used in referring to roasted Yulpi in this specification includes not only the crude extract obtained by treating the extraction solvent, but also the processed product of the roasted Yulpi extract. For example, the roasted Yulpi extract may be prepared in a powder state by additional processes such as distillation under reduced pressure and freeze drying or spray drying.
한편, 본 명세서에서 용어 '유효성분으로 함유하는'이란 로스팅 율피 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 일예로, 상기 로스팅 율피 추출물은 10 내지 1500 ㎍/㎖, 바람직하게는 100 내지 1000 ㎍/㎖의 농도로 사용된다. 로스팅 율피 추출물은 천연물로서 과량 사용하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 로스팅 율피 추출물의 양적 상한은 당업자가 적절한 범위 내에서 선택하여 실시할 수 있다.
Meanwhile, in the present specification, the term "contained as an active ingredient" means including an amount sufficient to achieve the efficacy or activity of the roasted Yulpi extract. As an example, the roasting yulpi extract is used in a concentration of 10 to 1500 ㎍ / ㎖, preferably 100 to 1000 ㎍ / ㎖. Roasting Yulpi extract is a natural product and does not have side effects on the human body even when used in excessive amounts. Therefore, the upper limit of the quantity of the roasting Yulpi extract included in the composition of the present invention can be selected and carried out within an appropriate range by a person skilled in the art.
본 발명의 화장료 조성물에는 상기의 화장료 조성물과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합할 수 있으며, 이러한 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한제, 정제수, 수용성 비타민, 지용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스 등을 들 수 있다.In the cosmetic composition of the present invention, in addition to the cosmetic composition described above, other ingredients that are usually blended in the cosmetic may be blended as needed, and such blending ingredients include fats and oils, moisturizers, emollients, surfactants, organic and inorganic pigments, Organic powders, UV absorbers, preservatives, disinfectants, antioxidants, pH adjusters, alcohols, pigments, fragrances, blood circulation accelerators, cooling agents, restrictors, purified water, water-soluble vitamins, fat-soluble vitamins, polymer peptides, polymer polysaccharides, sphingo lipids and seaweed Extract, etc. are mentioned.
본 발명의 화장료 조성물은 당업계에서 통상 사용되는 유화 제형 및 가용화 제형의 형태로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in the form of an emulsified formulation and a solubilized formulation commonly used in the art.
또한, 본 발명의 상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 성분 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 안료 및 천연향료와 같은 통상적인 보조제 및 담체를 더 포함할 수 있다.In addition, the ingredients included in the cosmetic composition of the present invention may include ingredients commonly used in cosmetic compositions in addition to the above ingredients as an active ingredient. For example, conventional auxiliary agents such as stabilizers, pigments and natural perfumes, and It may further include a carrier.
본 발명의 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 미스트, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 자외선 차단크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 마스크팩, 프레스파우더, 루스파우더, 아이섀도우 등과 같은 화장품류와 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저 등이 있다.Products to which the composition of the present invention can be added include, for example, mist, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrition lotion, massage cream, nutrition cream, sunscreen cream , Moisture Cream, Hand Cream, Foundation, Essence, Nutrition Essence, Mask Pack, Press Powder, Loose Powder, Cosmetics such as Eye Shadow, Soap, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion and Body Cleanser.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide may be used as a carrier component. I can.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additionally chlorofluorohydrocarbon, propane , Butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, a solvating agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.
When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracant, and the like may be used.
또한, 본 발명은 로스팅 율피 추출물을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition containing the roasting yulpi extract as an active ingredient.
건강기능식품이란, 로스팅 율피 추출물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 로스팅 율피 추출물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.
Health functional foods are foods prepared by adding roasted Yulpi extract to food ingredients such as beverages, teas, spices, chewing gums, confectionery, etc., or by encapsulation, powdering, or suspension. However, unlike general drugs, it has the advantage of not having side effects that may occur when taking drugs for a long time by using food as a raw material. The health functional food of the present invention obtained in this way is very useful because it can be consumed on a daily basis. The amount of roasting Yulpi extract added in such health functional foods cannot be uniformly regulated depending on the type of health functional food to be targeted, but can be added within the range that does not damage the original taste of the food. It is in the range of 0.01 to 50% by weight, preferably 0.1 to 20% by weight. In addition, in the case of health functional foods in the form of pills, granules, tablets or capsules, it is usually added in the range of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of a pill, tablet, capsule or beverage.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, a preferred embodiment is presented to aid in the understanding of the present invention, but it is obvious to those skilled in the art that various changes and modifications are possible within the scope of the present invention and the scope of the technical idea, but the following examples are only illustrative of the present invention, It is natural that such modifications and modifications fall within the scope of the appended claims.
실시예 1. 로스팅 율피 추출물_160 ℃Example 1. Roasting Yulpi extract_160 ℃
로스팅된 율피Roasted Yulpi
율피는 충남 부여에서 얻은 것을 사용하였으며, 로스팅에 앞서 수분함량이 40-50%인 율피를 분쇄기(J-ONE Co; SFM-0505S, Korea)로 분쇄한 뒤 거름망으로 여과하여 0.5 cm 이하인 것만 회수한 다음 로스팅기(팬지름이 27.8 cm인 평판회전형, MK-400, ㈜ MICKI, China)에 투입하였다.Yulpi obtained from Buyeo, Chungnam was used. Prior to roasting, Yulpi with a moisture content of 40-50% was pulverized with a grinder (J-ONE Co; SFM-0505S, Korea) and filtered through a strainer to recover only 0.5 cm or less. Next, it was put into a roasting machine (plate rotating type with a pan diameter of 27.8 cm, MK-400, MICKI, China).
로스팅기를 이용하여 회전날개의 회전수 4 rpm 조건에서 율피 로스팅을 진행하였다. 율피가 투입되기 전에 로스팅기의 온도를 160 ℃로 조절하였으며 상기 온도일 때 율피를 투입한 직후의 율피 표면온도는 30 ℃이고, 1분 경과 후 60-70 ℃로 상승하며 로스팅 완료시점인 4분에서 율피의 온도는 75-80 ℃에 도달하였다.Yulpi roasting was performed under the condition of a rotation speed of 4 rpm using a roaster. Before Yulpi was added, the temperature of the roasting machine was adjusted to 160 ℃, and at this temperature, the surface temperature of Yulpi immediately after Yulpi was added is 30 ℃, and after 1 minute it rises to 60-70 ℃, 4 minutes at the time of completion of roasting. In Yulpi, the temperature reached 75-80 °C.
초음파 추출Ultrasonic extraction
상기 로스팅된 율피와 50% 에탄올 수용액을 1 : 20의 중량비로 혼합하여 초음파기(JAC Ultrasinic, Hwaseng, Korea)에 투입 후 초음파(40 kHz, 200 W)를 이용하여 70 ℃에서 60분 동안 추출하였다. The roasted Yulpi and 50% ethanol aqueous solution were mixed at a weight ratio of 1:20, put into an ultrasonicator (JAC Ultrasinic, Hwaseng, Korea), and extracted at 70° C. for 60 minutes using ultrasonic waves (40 kHz, 200 W).
추출 시 튜브의 바닥면이 초음파 수조바닥에 닿지 않도록 스테인레스 랙(stainless rack)에 튜브를 고정시켜 추출을 진행하였으며, 추출 후 원심분리하여 상등액을 회수하고 필요에 따라 희석액을 만들어 생리활성물질 측정 및 미백과 주름방지 기능성 평가 실험에 사용하였다.
During extraction, the tube was fixed to a stainless rack so that the bottom of the tube did not touch the bottom of the ultrasonic bath, and the supernatant was collected by centrifugation after extraction, and a dilution solution was prepared as necessary to measure and whiten physiologically active substances. It was used in the evaluation test of anti-wrinkle functionality.
실시예 2. 로스팅 율피 추출물_200 ℃Example 2. Roasting Yulpi extract_200 ℃
상기 실시예 1과 동일하게 실시하되, 율피가 투입되기 전에 로스팅기의 온도를 200 ℃로 조절(율피를 투입한 직후의 율피 표면온도는 33 ℃)하여 로스팅 율피 추출물을 수득하였다.
In the same manner as in Example 1, the temperature of the roasting machine was adjusted to 200°C before the Yulpi was added (the surface temperature of Yulpi immediately after the Yulpi was added was 33°C) to obtain a roasted Yulpi extract.
실시예 3. 로스팅 율피 추출물_240 ℃Example 3. Roasting Yulpi extract_240 ℃
상기 실시예 1과 동일하게 실시하되, 율피가 투입되기 전에 로스팅기의 온도를 240 ℃로 조절(율피를 투입한 직후의 율피 표면온도는 37 ℃)하여 로스팅 율피 추출물을 수득하였다.
In the same manner as in Example 1, the temperature of the roasting machine was adjusted to 240° C. before Yulpi was added (the surface temperature of Yulpi immediately after the Yulpi was added was 37°C) to obtain a roasted Yulpi extract.
실시예 4. 로스팅 율피 추출물_280 ℃Example 4. Roasted Yulpi extract_280 ℃
상기 실시예 1과 동일하게 실시하되, 율피가 투입되기 전에 로스팅기의 온도를 280 ℃로 조절(율피를 투입한 직후의 율피 표면온도는 40 ℃)하여 로스팅 율피 추출물을 수득하였다.
In the same manner as in Example 1, the temperature of the roasting machine was adjusted to 280° C. before Yulpi was added (the surface temperature of Yulpi immediately after the Yulpi was added was 40°C) to obtain a roasted Yulpi extract.
비교예 1. 율피 추출물Comparative Example 1. Yulpi extract
상기 실시예 1과 동일하게 실시하되, 로스팅되지 않은 생율피를 사용하여 율피 추출물을 수득하였다.
It was carried out in the same manner as in Example 1, but the Yulpi extract was obtained using unroasted saengyulpi.
<시험예><Test Example>
시험예 1. 미백 및 주름방지 효과 측정_티로시나제(Tyrosinase) 억제 효과 및 콜라게나제(Collagenase) 억제Test Example 1. Measurement of whitening and anti-wrinkle effect_Tyrosinase inhibition effect and collagenase inhibition 효과 측정Measure the effect
실시예 및 비교예에 따라 제조된 추출물을 이용하여 미백과 피부재생의 지표인 tyrosinase inhibition activity (TIA)와 collagenase inhibition activity (CIA)를 측정하였다.Using the extracts prepared according to Examples and Comparative Examples, tyrosinase inhibition activity (TIA) and collagenase inhibition activity (CIA), which are indicators of whitening and skin regeneration, were measured.
상기 Tyrosinase는 기질인 L-tyrosine을 3,4-dihydroxy-L-phenylananine (DOPA)로 합성하고, L-DOPA를 phenylanine-3,4-quinone으로 산화하여 최종적으로 멜라닌을 합성하는 효소로서, 피부색이나 색소 침착 여부를 좌우하는 데 주요한 역할을 하여 피부 미백에 있어서 tyrosinase를 저해하는 활성이 중요시 되고 있다.The Tyrosinase is an enzyme that synthesizes L-tyrosine as a substrate into 3,4-dihydroxy-L-phenylananine (DOPA) and oxidizes L-DOPA to phenylanine-3,4-quinone to finally synthesize melanin. As it plays a major role in determining whether or not pigmentation is present, the activity of inhibiting tyrosinase in skin whitening is being regarded as important.
또한, 상기 피부 진피조직 속에서는 collagen과 elastin이 그물망 구조를 형성하고 있으며 특히 collagen은 피부 전체 건조 중량의 약 70-80%를 차지하여 분해될 시에는 그물망 구조가 처지게 되고 피부의 탄력 감소 및 주름 생성의 원인이 된다. 따라서 주름 생성을 억제하기 위해서는 collagen의 분해와 손실을 최소화해야 하며, 피부의 주름개선 기능성 분석에 있어서도 collagen을 분해하는 효소인 collagenase를 저해하는 활성이 중요시 되고 있다.In addition, in the dermal tissue of the skin, collagen and elastin form a network structure. In particular, collagen accounts for about 70-80% of the total dry weight of the skin. It becomes the cause of. Therefore, in order to suppress wrinkle formation, the decomposition and loss of collagen should be minimized, and the activity of inhibiting collagenase, an enzyme that decomposes collagen, is regarded as important in the functional analysis of skin wrinkle improvement.
1-1. 티로시나제 저해능(%): Tyrosinase는 피부의 표피 기저층에서 tyrosine을 산화시켜 멜라닌의 생성을 촉진시키는 효소로서 피부 미백과 노화 방지를 위해서는 tyrosinase의 활성 억제가 요구된다. 실험을 위해 sodium phosphate monobasic anhydrous와 sodium phosphate dibasic anhydrous을 이용하여 PH 6.8의 67 mM sodium phosphate buffer를 제조하였고 10 mM 3,4-dihydroxy phenylanin(I-dopa)과 mushroom tyrosinase(125 unit)는 buffer에 녹여 제조하였다. 최종 용액의 양이 1 mL가 되도록 시료용액 0.2 mL에 67 mM sodium phosphate buffer와 10 mM 3,4-dihydroxy phenylanin(I-dopa), mushroom tyrosinase를 혼합하여 water bath에 25 ℃에서 30분간 반응시켰다. 반응 후에는 dopachrome를 475 ㎚파장에서 흡광도를 측정하였다. 양성 대조군으로는 kojic acid를 사용하였다. Tyrosinase의 저해 활성은 하기 [수학식 1]에 따라 계산하였다.1-1. Tyrosinase inhibitory ability (%): Tyrosinase is an enzyme that promotes the production of melanin by oxidizing tyrosine in the base layer of the epidermis of the skin. In order to prevent skin whitening and aging, inhibition of tyrosinase activity is required. For the experiment, a 67 mM sodium phosphate buffer with a pH of 6.8 was prepared using sodium phosphate monobasic anhydrous and sodium phosphate dibasic anhydrous, and 10 mM 3,4-dihydroxy phenylanin (I-dopa) and mushroom tyrosinase (125 units) were dissolved in the buffer. Was prepared. 67 mM sodium phosphate buffer, 10 mM 3,4-dihydroxy phenylanin (I-dopa), and mushroom tyrosinase were mixed in 0.2 mL of the sample solution so that the amount of the final solution was 1 mL, and reacted in a water bath at 25° C. for 30 minutes. After the reaction, the absorbance of dopachrome was measured at a wavelength of 475 nm. As a positive control, kojic acid was used. The inhibitory activity of tyrosinase was calculated according to the following [Equation 1].
[수학식 1][Equation 1]
저해활성(%)=[1-(A/B)X100]Inhibitory activity (%)=[1-(A/B)X100]
A : Tyrosinase activity with sample, B : Tyrosinase activity without sampleA: Tyrosinase activity with sample, B: Tyrosinase activity without sample
1-2. 콜라게나제 저해능(%): Collagenase는 체내 collagen을 분해하여 주름생성과 탄력저하를 일으키는 효소로서 피부 노화의 원인이 되는 주름 생성을 억제하기 위해서는 collagenase의 저해가 요구된다. 실험에 필요한 buffer는 1 M Tris (hydroxylmetyl)Aminomethane와 4 mM CaCl2 (Calcium chloride), 1 M HCl을 이용하여 PH 7.5로 제조하였고 buffer로 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg와 collagenase를 제조하였다. 이어서 시료 0.05 mL에 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg를 첨가한 후 collagenase와 혼합하여 water bath에서 37 ℃로 20분간 반응시켰다. 반응 후에는 20% citric acid 0.25 mL을 넣어 collagenase 반응을 정지시킨 후, ethyl acetate 1.2 mL을 첨가하여 shaker에 10분간 교반하였다. 교반 후에는 상등액만 320 nm 파장에서 흡광도를 측정하였다. 양성 대조군으로는 ascorbic acid를 이용하였다. Collagenase 저해 활성은 하기 [수학식 2]에 따라 계산하였다.1-2. Collagenase inhibitory ability (%): Collagenase is an enzyme that decomposes collagen in the body to produce wrinkles and reduce elasticity. In order to suppress wrinkles that cause skin aging, inhibition of collagenase is required. The buffer required for the experiment was prepared at pH 7.5 using 1 M Tris (hydroxylmetyl) aminomethane, 4 mM CaCl 2 (Calcium chloride), and 1 M HCl, and 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d- Arg and collagenase were prepared. Subsequently, 4-phenyl azobenzyloxycarbonyl-pro-leu-gly-pro-d-arg was added to 0.05 mL of the sample, mixed with collagenase, and reacted in a water bath at 37° C. for 20 minutes. After the reaction, 0.25 mL of 20% citric acid was added to stop the collagenase reaction, and 1.2 mL of ethyl acetate was added, followed by stirring in a shaker for 10 minutes. After stirring, only the supernatant was measured for absorbance at a wavelength of 320 nm. Ascorbic acid was used as a positive control. Collagenase inhibitory activity was calculated according to the following [Equation 2].
[수학식 2][Equation 2]
저해활성(%)=[1-(A/B)X100]Inhibitory activity (%)=[1-(A/B)X100]
A : Collagenase activity with sample, B : Collagenase activity without sampleA: Collagenase activity with sample, B: Collagenase activity without sample
위 표 1에 나타낸 바와 같이, 본 발명의 실시예 1 내지 4에 따라 로스팅된 율피를 이용한 추출물은 생율피를 사용한 비교예 1에 비하여 티로시나제 저해능 및 콜라게나제 저해능이 우수한 것을 확인하였다.As shown in Table 1 above, it was confirmed that the extract using Yulpi roasted according to Examples 1 to 4 of the present invention had superior tyrosinase inhibitory ability and collagenase inhibitory ability as compared to Comparative Example 1 using Saengyulpi.
특히, 실시예 2에 따라 제조된 로스팅 율피 추출물은 다른 군에 비하여 티로시나제 저해능 및 콜라게나제 저해능이 월등히 우수한 것을 확인하였다.
In particular, it was confirmed that the roasting yulpi extract prepared according to Example 2 was significantly superior in tyrosinase inhibitory ability and collagenase inhibitory ability compared to other groups.
시험예 2. 생리활성물질 측정_DPPH 라디칼 소거능, 총 폴리페놀 및 총 플라보노이드 측정Test Example 2. Measurement of physiologically active substances_DPPH radical scavenging ability, total polyphenols and total flavonoids
2-1. DPPH 라디칼 소거능(%): DPPH(2,2-Diphenyl-1-picrylhydrazyl, Sigma-Aldrich) free radical 소거활성을 측정하는 Lee등의 방법을 변형하여 사용하였다. 라디칼이 항산화 물질로 인하여 환원되면 고유의 보라색을 잃고 노란색으로 변색되는데 이를 흡광도로 계산하여 라디칼 소거능을 측정하였다. DPPH 시약을 MtOH로 희석하여 분광광도계를 이용해 517 nm에서 O.D 값을 1.0로 맞춰 DPPH 희석액을 준비한다. 준비한 시료 0.25 ml에 희석한 DPPH 시약 1.25 ml를 가하여 암실에서 20분간 정치반응 후 원심분리하여 517 nm에서 흡광도를 측정하고 대조군과 비교하여 아래와 같이 free radical 소거활성을 백분율로 표현하였다. 대조군으로는 ascorbic acid(CAS 50-81-7, Sigma, USA)를 이용하였다.2-1. DPPH radical scavenging activity (%): DPPH (2,2-Diphenyl-1-picrylhydrazyl, Sigma-Aldrich) Free radical scavenging activity was measured by Lee et al. When radicals are reduced due to antioxidants, their intrinsic purple color is lost and the color changes to yellow. This was calculated by absorbance to measure the radical scavenging ability. Dilute the DPPH reagent with MtOH and prepare a DPPH dilution by setting the O.D value to 1.0 at 517 nm using a spectrophotometer. To 0.25 ml of the prepared sample, 1.25 ml of the diluted DPPH reagent was added, followed by a static reaction for 20 minutes in the dark, followed by centrifugation to measure the absorbance at 517 nm, and compared with the control group, the free radical scavenging activity was expressed as a percentage as follows. Ascorbic acid (CAS 50-81-7, Sigma, USA) was used as a control.
[수학식 3][Equation 3]
라디칼 소거활성(%)={1-(Abs(test)-Abs(color))/Abs(control)}X100Radical scavenging activity (%)={1-(Abs (test) -Abs (color) )/Abs (control) }X100
2-2. 총 폴리페놀: 총 폴리페놀(Total Polyphenol Content) 함량은 변형된 Folin-Ciocalteu's 방법을 이용하여 측정하였다. Folin-Ciocalteu's 페놀 용액(Folin & Ciocalteu's phenol; Sigma-Aldrich, USA)을 시료에 첨가하여 폴리페놀 화합물에 의해 환원되어 청색으로 발색되는 원리에 근거하여 흡광도 변화로 시료의 총 폴리페놀 농도를 측정하였다. 각 시료 0.14 mL를 취하고 0.2 N F.C 페놀용액을 0.7 mL 가하여 8분간 실온에 반응시켰다. 0.56 mL의 7.5% Sodium carbonate 용액을 첨가하여 실온에서 1시간 반응시킨 후 10초간 vortexing하고 분광광도계(Optizen 2102UV, Mecasys, Korea)로 756 nm에서 흡광도를 측정하였다. 표준물질로 Gallic acid (Sigma-Aldrich, USA)를 사용하였고 총 폴리페놀 함량은 Gallic acid를 농도별로 희석하여 검량선을 작성한 후 mg Gallic Acid Equivalent (GAE) / g Dried Material (DM)으로 표시하였다. 2-2. Total Polyphenol: Total Polyphenol Content was measured using a modified Folin-Ciocalteu's method. Folin-Ciocalteu's phenol solution (Folin & Ciocalteu's phenol; Sigma-Aldrich, USA) was added to the sample, and the total polyphenol concentration of the sample was measured by changing the absorbance based on the principle that it was reduced by the polyphenol compound and colored blue. 0.14 mL of each sample was taken, 0.7 mL of 0.2 N F.C phenol solution was added and reacted at room temperature for 8 minutes. 0.56 mL of 7.5% sodium carbonate solution was added, reacted at room temperature for 1 hour, vortexed for 10 seconds, and absorbance was measured at 756 nm with a spectrophotometer (Optizen 2102UV, Mecasys, Korea). Gallic acid (Sigma-Aldrich, USA) was used as a standard material, and the total polyphenol content was expressed as mg Gallic Acid Equivalent (GAE) / g Dried Material (DM) after preparing a calibration curve by diluting Gallic acid by concentration.
2-3. 총 플라보노이드: 총 플라보노이드(Total Flavonoid Content) 함량은 Zhishen 등의 방법을 변형하여 사용하였다. 플라보노이드에 알칼리를 적용시키면 황색으로 발색되는 원리에 근거하여 흡광도를 측정해 총 플라보노이드 농도를 측정하였다. 각 시료 0.5 mL에 DW 2.5 ml와 99% 에탄올 1.5 ml 가한 후 1M potassium acetate 0.1 ml와 10% aluminum chloride 0.1 ml를 가하여 vortexing 후 실온에서 30분간 방치하였다. 415 nm에서 흡광도를 측정하였으며 quercetin(Sigma-Aldrich, USA)을 200, 100, 50, 25 ul/ml로 농도 별로 희석하여 검량선을 구하여 플라보노이드 함량을 mg Quercetin Equivalent (QE) / g Dried Material (DM)로 나타내었다. 2-3. Total Flavonoids: Total Flavonoid Content was used by modifying the method of Zhishen et al. When an alkali was applied to the flavonoid, the absorbance was measured based on the principle that a yellow color was developed to measure the total flavonoid concentration. After adding 2.5 ml of DW and 1.5 ml of 99% ethanol to 0.5 ml of each sample, 0.1 ml of 1M potassium acetate and 0.1 ml of 10% aluminum chloride were added, vortexed, and left at room temperature for 30 minutes. Absorbance was measured at 415 nm, and quercetin (Sigma-Aldrich, USA) was diluted to 200, 100, 50, 25 ul/ml by concentration to obtain a calibration curve, and the flavonoid content was measured in mg Quercetin Equivalent (QE) / g Dried Material (DM). Represented by.
(%)Antioxidant activity
(%)
(mg GAE/mg DW)Total polyphenols
(mg GAE/mg DW)
(mg QE/mg DW)Total flavonoids
(mg QE/mg DW)
위 표 2에 나타낸 바와 같이, 본 발명의 실시예 1 내지 4에 따라 로스팅된 율피를 이용한 추출물은 생율피를 사용한 비교예 1에 비하여 1에 비하여 항산화능, 총 폴리페놀 및 총 플라보노이드가 높은 것을 확인하였다.As shown in Table 2 above, it was confirmed that the extract using Yulpi roasted according to Examples 1 to 4 of the present invention had higher antioxidant capacity, total polyphenols, and total flavonoids compared to Comparative Example 1 using Saengyulpi. I did.
특히, 항산화능 및 총 폴리페놀은 실시예 2가 가장 우수하며, 온도 증가에 따라 총폴리페놀 함량이 감소하여 폴리페놀의 온도민감성이 확인되었다.Particularly, the antioxidant activity and total polyphenols were the best in Example 2, and the total polyphenol content decreased with increasing temperature, confirming the temperature sensitivity of the polyphenol.
더욱이, 실시예 4와 비교예 1의 총 폴리페놀 차이는 유의하지 않음이 확인되어 높은 온도에서 총 폴리페놀의 열분해에 의해 생산이 감소함을 알 수 있었다. Moreover, it was confirmed that the difference between the total polyphenols in Example 4 and Comparative Example 1 was not significant, and it was found that the production was reduced by pyrolysis of the total polyphenols at a high temperature.
총 플라보노이드의 경우에는 총 폴리페놀과는 다르게 모든 온도범위에서 로스팅의 효과가 유의하게 보였으며(*P<0.05), 로스팅 온도가 증가함에 따라 총 플라보노이드 생산이 비례하여 증가하는 경향성을 보여 총 플라보노이드가 총 폴리페놀에 비해 열민감성이 낮다고 사료된다.In the case of total flavonoids, unlike total polyphenols, the effect of roasting was significant in all temperature ranges (*P<0.05), and the total flavonoid production tended to increase proportionally as the roasting temperature increased. It is thought that the thermal sensitivity is lower than that of total polyphenols.
이와 함께 항산화능은 폴리페놀과 같이 온도 증가에 따라 증가하는 경향을 보였지만 200 ℃ 이상에서 감소하는 것이 확인되어 항산화능에 총 폴리페놀의 기여도가 큰 것으로 사료된다.
In addition, antioxidant activity showed a tendency to increase with increasing temperature like polyphenol, but it was found to decrease above 200 ℃, so it is thought that the contribution of total polyphenol to antioxidant activity is large.
하기에 본 발명의 분말을 함유하는 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, examples of the formulation of the composition containing the powder of the present invention will be described, but the present invention is not intended to limit it, but is intended to be described in detail.
제제예 1. 과립제의 제조Formulation Example 1. Preparation of granules
실시예 1에서 얻은 추출물 1,000 mg1,000 mg of extract obtained in Example 1
비타민 혼합물 적량The right amount of vitamin mixture
비타민 A 아세테이트 70 ㎍Vitamin A acetate 70 ㎍
비타민 E 1.0 mg1.0 mg of vitamin E
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mg0.5 mg of vitamin B6
비타민 B12 0.2 ㎍Vitamin B12 0.2 ㎍
비타민 C 10 mg10 mg of vitamin C
비오틴 10 ㎍Biotin 10 ㎍
니코틴산아미드 1.7 mg1.7 mg of nicotinic acid amide
엽산 50 ㎍Folic acid 50 ㎍
판토텐산 칼슘 0.5 mg0.5 mg of calcium pantothenate
무기질 혼합물 적량Suitable amount of inorganic mixture
황산제1철 1.75 mgFerrous sulfate 1.75 mg
산화아연 0.82 mgZinc oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mgDicalcium phosphate 55 mg
구연산칼륨 90 mg90 mg of potassium citrate
탄산칼슘 100 mg100 mg of calcium carbonate
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 과립제에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 과립제 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.
The composition ratio of the vitamin and mineral mixture is relatively suitable for granules, but it is also possible to arbitrarily modify the mixing ratio. After mixing the above ingredients according to a conventional granule preparation method, granules And, according to a conventional method, it can be used for preparing a health functional food composition.
제제예 2. 기능성 음료의 제조Formulation Example 2. Preparation of functional beverage
실시예 1에서 얻은 추출물 1,000 mg1,000 mg of extract obtained in Example 1
구연산 1,000 mg1,000 mg citric acid
올리고당 100 g100 g oligosaccharides
매실농축액 2 g2 g of plum concentrate
타우린 1 g1 g taurine
정제수를 가하여 전체 900 mL900 mL total by adding purified water
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다. After mixing the above ingredients according to the normal health drink manufacturing method, stirring and heating the mixture at 85°C for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed and sterilized, and then stored in a refrigerator. It is used to prepare the functional beverage composition of the present invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.
The composition ratio is a mixture of ingredients suitable for a relatively preferred beverage in a preferred embodiment, but the mixing ratio may be arbitrarily modified according to regional and ethnic preferences such as the demand class, the country of demand, and the purpose of use.
본 발명을 적용하기에 적합한 화장료 조성물의 제조예를 제시하기로 한다.An example of preparing a cosmetic composition suitable for applying the present invention will be presented.
제조예 3: 화장수Preparation Example 3: Lotion
실시예 1의 로스팅 율피 추출물을 포함하는 화장료 중 화장수의 제조예는 하기 표 3와 같다.Examples of the preparation of the lotion among the cosmetics containing the roasted Yulpi extract of Example 1 are shown in Table 3 below.
제조예Manufacturing example 4: 로션 4: lotion
실시예 1의 로스팅 율피 추출물을 포함하는 화장료 중 로션의 제조예는 하기 표 4와 같다.Examples of the preparation of lotions among the cosmetics containing the roasting yulpi extract of Example 1 are shown in Table 4 below.
제조예Manufacturing example 5: 영양 크림 5: nourishing cream
실시예 1의 로스팅 율피 추출물을 포함하는 화장료 중 영양 크림의 제조예는 하기 표 5와 같다.Examples of the preparation of a nourishing cream among cosmetics containing the roasting yulpi extract of Example 1 are shown in Table 5 below.
제조예Manufacturing example 6: 에센스 6: essence
실시예 1의 로스팅 율피 추출물을 포함하는 화장료 중 에센스의 제조예는 하기 표 6과 같다.Examples of the preparation of the essence in the cosmetic composition containing the roasted Yulpi extract of Example 1 are shown in Table 6 below.
제조예Manufacturing example 7: 마스크 7: mask 팩용For pack 유액 latex
실시예 1의 로스팅 율피 추출물을 포함하는 화장료 중 마스크 팩용 유액의 제조예는 하기 표 7과 같다.Examples of the preparation of the emulsion for a mask pack among the cosmetics containing the roasted yulpi extract of Example 1 are shown in Table 7 below.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190132751A KR20210048729A (en) | 2019-10-24 | 2019-10-24 | Compositions containing roasted chestnut inner skin extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190132751A KR20210048729A (en) | 2019-10-24 | 2019-10-24 | Compositions containing roasted chestnut inner skin extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210048729A true KR20210048729A (en) | 2021-05-04 |
Family
ID=75913883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190132751A KR20210048729A (en) | 2019-10-24 | 2019-10-24 | Compositions containing roasted chestnut inner skin extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210048729A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010081359A (en) | 2000-02-14 | 2001-08-29 | 전병관 | chestnut tea (C tea) |
KR101671909B1 (en) | 2014-12-12 | 2016-11-03 | 주식회사 명진에프앤비 | Method for producing CHESTNUT INNER SKIN fermented beverage and CHESTNUT INNER SKIN fermented beverage produced by the same |
-
2019
- 2019-10-24 KR KR1020190132751A patent/KR20210048729A/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010081359A (en) | 2000-02-14 | 2001-08-29 | 전병관 | chestnut tea (C tea) |
KR101671909B1 (en) | 2014-12-12 | 2016-11-03 | 주식회사 명진에프앤비 | Method for producing CHESTNUT INNER SKIN fermented beverage and CHESTNUT INNER SKIN fermented beverage produced by the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101936294B1 (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR20070041927A (en) | Composition comprising an extract of persicae flos having anti-oxidizing, anti-cancer, whitening activities | |
KR102399204B1 (en) | Compositions containing black garlic extract | |
KR102370528B1 (en) | Compositions containing Beta vulgaris fermentation extract | |
KR102479408B1 (en) | Compositions containing Sargassum horneri (Turner) C. Agardh extract | |
KR101912996B1 (en) | Cosmetic Composition comprising extract of Oplismenus undulatifolius | |
KR102128168B1 (en) | Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect | |
KR20210048729A (en) | Compositions containing roasted chestnut inner skin extract | |
Marnewick | Antioxidant properties of Rooibos (Aspalathus linearis)–in vitro and in vivo evidence | |
KR102293782B1 (en) | Compositions containing peanut shell extract | |
KR102401490B1 (en) | Compositions containing Angelica gigas extract | |
KR100702891B1 (en) | Cosmetic composition comprising an extract of Lespedeza bicolor having anti-oxidative activity | |
KR102612332B1 (en) | Compositions for skin whitening and anti-wrinkle containing fermented moringa extract | |
KR102307176B1 (en) | compositions containing by-product extract of Allium sativum L. | |
KR102449136B1 (en) | Compositions containing Taraxacum coreanum extract | |
KR102572519B1 (en) | A cosmetic composition for skin whitening containing loess extract | |
KR102619963B1 (en) | Compositions for skin whitening, anti-wrinkle and UV protection containing fermented chestnut inner skin extract | |
KR101461704B1 (en) | Composition for protecting skin and inhibiting damage of skin against UV Comprising Polysiphonia morrowii Harvey | |
US20230181451A1 (en) | Steamed glycyrrhiza sp. extract with increased glycyrrhetinic acid contents and preparation method thereof | |
KR102334191B1 (en) | Functional cosmetic composition comprising potato | |
KR20130070107A (en) | A method for preparing functional green tea extract comprising abundant functional ingredient and the cosmetic composition comprising the same having potent anti-wrinkle activity | |
KR20240003565A (en) | Antioxidant composition containing Chaga ultrasonic wave fermentation extract | |
KR20230046573A (en) | Cosmetic composition comprising extracts of clove for anti-oxidation, anti-wrinkle, improving skin elasticity and skin whitening | |
KR100815873B1 (en) | A cosmetic composition comprising an extract of ailanthus altissima having antioxidative effect | |
KR20240003564A (en) | Compositions containing Orostachydis Herba extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |